Leilei Huffman, MD
Dermatology · Stafford, VANPI 1225167554
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 36.9% of the total. 2025 is the largest year on record at $212, more than ten times the $17 reported in 2019. That places this record below the midpoint for dermatology clinicians in VA, where the typical reported total is $1,785.
Across 12 payments — averaging $34.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$152
- Incyte Corporation$77
- Pfizer$39
- Boehringer Ingelheim$35
- Biofrontera Inc.$25
- Johnson & Johnson$24
- plus $60 from 3 others
What the payments were for
- Food & beverage$39997%
- Education$133%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $152 |
| Incyte Corporation | 2 | $77 |
| Pfizer | 1 | $39 |
| Boehringer Ingelheim | 1 | $35 |
| Biofrontera Inc. | 2 | $25 |
| Johnson & Johnson | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Galderma Laboratories, L.p. | 1 | $19 |
| DUSA Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$128
How this compares
$412 in reported general payments places this provider in the 25th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 64 | $6,235 |
| Desonide | 21 | $1,672 |
| Cephalexin | 11 | $937 |
| Ketoconazole | 50 | $814 |
| Triamcinolone Acetonide | 65 | $620 |
| Clindamycin Phosphate | 22 | $539 |
| Nystatin | 26 | $355 |
| Mupirocin | 14 | $114 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Stafford
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
- David PariserNorfolk$261K
- Hema SundaramFairfax$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.